Tawuniya: The Sovereign Underwriter of the Saudi Boom

I. Introduction & Episode Roadmap

Certain enterprises are uniquely the product of state initiative. They are not traditional state-owned companies — no ministry dictates their pricing, and no bureaucrat manages their claims — but they exist because a government determined a market should exist, and subsequently built the framework to support it.

In January 1986, a Saudi joint-stock company was registered in Riyadh under commercial registration number 1010061695, established by Royal Decree Number M/5 issued the prior year.¹ Its initial purpose was systemic: to demonstrate that insurance — a sector viewed with skepticism by the domestic religious establishment — could operate in compliance with Islamic law. Capitalized by state pension funds, the company initially operated without a retail brand, an extensive distribution network, or a market where purchasing insurance was mandatory.

This origin differs from typical industry paths. While most insurers design products around customer demand, this enterprise was established to address a jurisprudential challenge. The founding inquiry focused not on identifying customer needs, but on whether insurance could be structured to comply with Islamic principles. The Kingdom's resolution was to establish a corporate model demonstrating that it could.

Four decades later, that experiment is the largest insurer in the Middle East by premium. In the financial year ended December 2025, الشركة التعاونية للتأمين Al-Sharika Al-Tawuniya lil-Ta'min — universally known as التعاونية Tawuniya, and traded on تداول Tadawul as 8010.SR — reported insurance revenue of 21.4 billion Saudi riyals, or approximately 5.7 billion dollars. This represented a 17.1 percent increase over the previous year, supported by gross written premiums of 23.8 billion riyals.² Within a Saudi market that generated 71.2 billion riyals in insurance revenue across twenty-four listed carriers, Tawuniya accounted for nearly thirty percent of all industry revenue.³

A central paradox defines the company. Tawuniya is legally structured as a cooperative insurer. Under the regulatory framework governing licensed carriers in the Kingdom, ten percent of the net surplus from insurance operations must be returned to policyholders — either in cash or through premium reductions — while the remaining ninety percent is allocated to the shareholders' income statement.⁴ Although designed as a theological accommodation to treat policyholders as mutual participants in a shared risk pool rather than counterparties in a speculative contract, the company operates as a highly commercial enterprise. Over the past five years, it has expanded its market share, underwritten major giga-project construction risks, launched a digital insurance brand, opened proprietary clinics, and established a wholly owned reinsurance subsidiary.

This raises the question of how a mutualist legal framework supports a commercially driven growth story. For investors, the critical assessment is what protects Tawuniya's dominant position and what factors could disrupt it.

A second paradox complicates the investment thesis. While the company's growth over the past five years has been rapid, a significant portion of this expansion was driven by state regulatory mandates rather than direct competitive gains. Although medical and motor insurance have long been compulsory in Saudi Arabia, these requirements were not strictly enforced for nearly two decades. When the government began systematic enforcement, the entire industry experienced a simultaneous influx of demand. Disentangling Tawuniya's organic competitive performance from this policy-driven growth is a primary analytical challenge.

This analysis examines the company's trajectory across several key areas: the state-supported origins of Saudi cooperative insurance and the religious compliance issues it addressed; the regulatory shifts that transformed a specialist commercial insurer into a retail giant; the financial drivers of its medical, motor, and property and casualty segments; the 2023 leadership transitions that connected Tawuniya's management with its largest shareholder and its regulator; the strategic choice to build internal capabilities rather than acquire them; a competitive assessment using Porter's Five Forces and Hamilton Helmer's Seven Powers; the broader business lessons; and a balanced investment case. Finally, it reviews the first half of 2026, during which earnings declined, and details the factors management cited for the performance.

This recent performance downturn provides a critical point of evaluation. Growth trends are straightforward to analyze when financial results are favorable. The more significant test of a franchise's long-term durability, as opposed to temporary regulatory benefit, is how it navigates periods of slowing growth.

↑ Back to Top

II. The State-Backed Genesis: Cooperative Insurance in the Kingdom (1986–2003)

During the early 1980s, oil revenues rapidly transformed the physical infrastructure of Saudi Arabia, bringing a massive concentration of capital assets including refineries, ports, hospitals, and highways. Although these projects created significant risk exposure, very little of it was underwritten domestically.

Instead, offshore brokers in hubs like London, Bahrain, and Beirut managed Saudi industrial risk, collecting premiums and settling claims abroad. As a result, the Kingdom exported both its risk and the corresponding investment float, leaving domestic authorities with minimal supervisory oversight. This reliance on offshore markets was driven not by commercial capacity, but by doctrinal barriers.

The problem with a promise

Classical Islamic jurisprudence identifies two primary conflicts in conventional insurance contracts. The first is gharar (غرر), or excessive uncertainty. In a standard insurance contract, the policyholder pays a fixed premium for a payout that may never be triggered; if a loss does occur, the compensation can far exceed the premium paid. Consequently, neither party knows the exact value of what is being exchanged at the time of agreement. The second conflict is riba (ربا), the prohibition on interest, which directly affects how conventional insurers manage their premium float. Because conventional insurers historically operated similarly to leveraged investment funds backed by underwriting operations, their dependence on interest-bearing assets was difficult to reconcile with Islamic law.

To address these concerns, scholars and policymakers across the Islamic world developed a cooperative model (تأمين تعاوني) in the latter half of the twentieth century. Under this framework, participants contribute to a collective pool, and the operator manages the fund for a fee. Losses are paid directly from this shared pool, and any remaining surplus theoretically belongs to the participants. In this structure, the company serves as an administrator rather than a counterparty, mutualizing risk rather than transferring it.

Tawuniya was established to implement this cooperative model. Because the company was founded by the Saudi state rather than private entrepreneurs, its initial purpose was institutional rather than commercial. The government sought to establish a domestically licensed insurer that demonstrated regulatory and theological compliance.

Sovereign money as founding capital

Tawuniya's initial capital was provided by the two entities holding the largest pools of long-term domestic savings: the General Organization for Social Insurance (GOSI), which managed social insurance for private-sector workers, and the Public Pension Agency, which served the civil service. Together with public investors, these state pension institutions formed the shareholder base and held a controlling interest.¹

The primary strategic advantage of this ownership structure was not capital, but distribution. Because its major shareholders maintained employment and retirement records for the country's workforce, and the Saudi government was the largest buyer of infrastructure, aviation, energy, and medical risk coverage, the company occupied a unique market position. Tawuniya did not need to build retail brand recognition; its ownership made it the default partner for public and corporate risk.

This structural support complicates the narrative of Tawuniya as a national champion whose dominance was built purely on operational excellence. During its first two decades, the company’s market position was largely protected. Its underwriting focused on commercial lines—such as energy, engineering, aviation, marine, and fire protection—where the customer base was concentrated, sophisticated, and heavily linked to the state. Rather than competing for retail customers, Tawuniya primarily allocated capacity to a secure, institutional market.

The mathematics of the cooperative wrapper

The cooperative surplus-sharing mechanism is sometimes misconstrued as a significant limit on profitability compared to conventional insurance models.

Under the implementing regulations that later formalized the system across the Saudi insurance sector, 90 percent of the net underwriting surplus is allocated to shareholders, while 10 percent is returned to policyholders.⁴ While this cooperative framework introduces an economic cost, the impact is confined to the underwriting surplus rather than total revenue. Shareholders retain 90 percent of the underwriting margin along with all investment income generated from the premium float. By mid-2026, Tawuniya’s investment portfolio reached approximately 13.5 billion riyals, generating hundreds of millions of riyals annually in net investment income.⁵ Consequently, the underlying economics of managing and investing premium float remain very similar to those of conventional insurers.

Ultimately, the cooperative structure provided institutional legitimacy. This model made insurance acceptable in a market where many corporate and retail customers would have otherwise avoided the sector on doctrinal grounds. It also established a regulatory template: when Saudi Arabia later opened the sector to wider competition, every newly licensed insurer was required to adopt the same cooperative framework.

This regulation gave Tawuniya a distinct first-mover advantage, establishing the operational model that would become the industry standard. The company operated for 17 years as the only licensed domestic insurer in a market where insurance was not yet mandatory. The transition to a high-growth retail market would ultimately be driven not by new product development, but by sweeping regulatory changes.

↑ Back to Top

III. The Regulatory Boom: From Voluntary to Mandatory Coverages (2003–2015)

Most insurance markets experience a transition when coverages shift from voluntary purchases to statutory requirements. In the United States, this transition was driven by state-by-state automobile financial-responsibility laws. In Saudi Arabia, a similar shift occurred twice within a decade, and the cumulative impact of these two mandates became a primary driver of Tawuniya's financial growth.

The law that built an industry

On 31 July 2003, a Royal Decree enacted the Cooperative Insurance Companies Control Law.⁶ While technical in its details, the law fundamentally restructured the domestic market.

The legislation introduced three major changes simultaneously. First, it prohibited offshore, unlicensed insurance operations, ending the arrangements in Bahrain and London that had absorbed Saudi risk for decades. Second, it required every insurer operating in the Kingdom to incorporate locally as a publicly listed joint-stock company structured under cooperative principles. Finally, it transferred supervisory authority to the Saudi Central Bank, البنك المركزي السعودي (SAMA), which established capital minimums, solvency rules, reserving standards, and—under Article 70 of the implementing regulations—the surplus-distribution formula.

This reform turned Tawuniya's cooperative framework into national policy. Underwriting premiums that previously left the country remained within the domestic financial system, and capital seeking exposure to Saudi risk was required to establish local entities capitalized in Riyadh and listed on the Saudi Exchange. Consequently, Tawuniya, which had served as the prototype, became the primary incumbent in a market that saw more than two dozen newly licensed competitors emerge over the subsequent years.

Tawuniya was formally licensed under this new regulatory regime in December 2004 and listed on the Saudi Exchange on 12 March 2005 under the symbol 8010.⁷ Rather than simply raising capital, the listing established a public valuation for the company and introduced market discipline through quarterly disclosures, share price tracking, and sell-side research coverage.

Two mandates, twenty years of tailwind

The first mandate addressed medical coverage. Saudi Arabia's Cooperative Health Insurance Law was enacted in 1999, with implementation occurring in stages: compulsory employer-provided coverage for non-Saudi workers was extended in 2005, and then expanded in 2008 to cover Saudi nationals employed in the private sector.⁸ This structure proved advantageous for insurers. Because employers purchase the policies on behalf of their employees, renewals occur annually, and residency permits for expatriate workers are linked to active health coverage, non-compliance carries direct immigration consequences rather than simple financial penalties.

The second mandate focused on motor insurance. Third-party liability coverage became compulsory for all registered vehicles under a Council of Ministers resolution in the early 2000s. However, the commercial impact of this mandate depended heavily on the timing and consistency of its enforcement.

The enforcement gap: the real growth engine

For nearly two decades, both mandates were legally in force but faced incomplete enforcement. The regulatory infrastructure lacked the tools to systematically verify whether vehicles on the road carried active policies. Furthermore, the introduction of value-added tax in 2018 and the onset of the pandemic in 2020 delayed stricter enforcement efforts, as regulators avoided placing additional immediate financial burdens on household budgets.

This enforcement gap narrowed with the introduction of new monitoring technologies. In October 2023, the General Department of Traffic launched automated electronic monitoring of motor insurance status, verifying vehicles roughly every fifteen days. Because this system detected uninsured vehicles independently of other traffic violations, drivers could be fined between 100 and 150 riyals solely for lack of coverage.⁹ The policy led to immediate changes in the market. The rate of insured vehicles relative to registered cars, which stood at 42 percent in 2021 and 51 percent in 2022, rose to 65 percent in 2023 and reached approximately 68 percent by the third quarter of 2024.⁹

From a business perspective, this 17-percentage-point increase in compliance represented a significant expansion in the addressable market, achieved without product development or marketing expenses. Because coverage was already legally required, volume growth was driven primarily by state enforcement.

A similar compliance gap has remained on the medical side. Analysis of Insurance Authority and industry data indicated that over 26 percent of employed individuals in the Kingdom still lacked valid medical insurance as of late 2024. This represented an estimated 3.1 million uninsured lives, consisting of approximately 2.2 million expatriates and at least 900,000 Saudi nationals.⁹ With an average premium per insured life of about 3,500 riyals, closing this enforcement gap completely would add approximately 10.9 billion riyals of medical premiums to the market. This figure represents the unrealized potential of the existing statutory mandate rather than an organic growth projection.

What the boom actually did to Tawuniya

These dynamics altered Tawuniya's corporate profile. The company, which had historically focused on industrial and commercial underwriting, transitioned into a high-volume retail insurer. By the first quarter of 2025, health insurance had come to dominate Tawuniya's business, accounting for 81 percent of its gross written premiums. Motor insurance made up 11 percent, general insurance accounted for seven percent, and protection and savings contributed approximately one percent.¹⁰ While this product mix reflected seasonal factors—as large corporate medical schemes renew disproportionately in the first quarter—it highlighted the structural shift toward health coverage.

Across the entire Saudi market, medical policies represented 57.3 percent of the 83.2 billion riyals in gross written premiums in 2025. Motor coverage followed at 17.9 percent, while property and casualty insurance accounted for 15.0 percent.³ This expansion was reflected in the country's insurance density, which more than doubled from 1,093 riyals per capita in 2020 to 2,370 riyals in 2025.³

This environment alters the operational priorities of a domestic insurer. In a market where coverage is mandated, customer acquisition costs remain relatively low because demand is statutory. Under these conditions, profitability depends less on sales growth and more on technical underwriting discipline and claims cost management. While state regulations drive premium volume, generating consistent margins requires operational efficiency and accurate risk pricing.

↑ Back to Top

IV. The Core Business Under the Microscope: Health, Motor, and P&C

Strip away the strategy decks and an insurer is three numbers: what you charge, what you pay out, and what you earn on the money in between. Tawuniya runs three quite different businesses against that arithmetic, and they behave nothing like each other.

Medical: the duopoly and the hospital problem

The Saudi health insurance market is, in practice, a two-horse race with a long tail. On 2025 gross written premium, Tawuniya wrote SAR 23.8 billion in total and Bupa Arabia SAR 20.5 billion, with تكافل الراجحي Al Rajhi Takaful a distant third at SAR 10.6 billion.³ Within medical specifically, the concentration is starker still: sell-side analysis of 2023 data put Tawuniya at roughly 32% share and Bupa Arabia ahead of it, with the two together accounting for close to 78% of the entire medical insurance market.⁹

Bupa Arabia is the reason this segment is a genuine competitive contest rather than an incumbent's inheritance. It is a mono-liner — health and nothing else — with a global parent's underwriting methodology and decades of Saudi-specific claims data. For years it was the largest insurer in the Kingdom outright. That changed. On 2025 numbers, Tawuniya's insurance revenue of SAR 21.4 billion exceeded Bupa Arabia's SAR 19.3 billion, and Tawuniya's net profit of SAR 1.10 billion edged past Bupa Arabia's SAR 1.08 billion.²¹¹ More telling than the levels is the direction: Tawuniya's insurance revenue grew 17.1% in 2025 while Bupa Arabia's grew 6.6%, and Bupa Arabia's net income fell from SAR 1.17 billion the prior year.²¹¹

That is a real share shift, and it is the strongest single piece of evidence for the bull case. But it is worth being precise about what it does and does not prove. Winning share in a mandated market can mean superior distribution and service — or it can mean pricing more aggressively than the competitor. Those look identical for two or three years and then diverge violently. We will return to that.

The genuine economic engine in medical is not pricing at all. It is the cost of care. An insurer's medical claims bill is set by what hospitals charge and how often patients use them, and in Saudi Arabia the provider side has consolidated into a small number of powerful private groups — مجموعة الدكتور سليمان الحبيب الطبية the Dr. Sulaiman Al Habib Medical Group and المواساة Mouwasat prominent among them — that dominate urban catchments.

Here scale genuinely matters. An insurer covering millions of lives negotiates unit prices from a very different position than one covering a hundred thousand, because the provider stands to lose a material share of its patient flow if the network agreement lapses. This is the clearest instance of scale economies in the business: the same procedure costs the large insurer less than the small one, and the gap compounds across every claim.

But the power runs both directions. A hospital group with the dominant tertiary facility in a major city is not easily excluded from a network, because corporate clients buy insurance partly on the strength of the network. When the leading providers demand tariff increases, the large insurer's options are to absorb the cost, pass it to policyholders at renewal, or accept a narrower network and risk losing accounts. Saudi private medical inflation has been persistently elevated since 2020, driven by base inflation of roughly 5–6% plus specific regulatory effects — the migration of claims onto a national digital exchange, a crackdown on duplicate policies, and successive expansions of the mandated table of benefits.⁹

An additional wrinkle sits in the background: the pending shift from fee-for-service reimbursement to Diagnosis-Related Group (DRG) payment. Under fee-for-service, a hospital is paid per item — every test, every night, every consultation — which rewards volume. Under DRG, the hospital receives a fixed amount for treating a defined condition, which shifts the cost of over-treatment onto the provider. Insurers have welcomed it. Implementation timelines have repeatedly slipped, and evidence from the UAE's DRG transition suggests the loss-ratio benefit, if it arrives at all, arrives slowly.⁹ Investors should treat DRG as optionality, not as a modelled saving.

Tawuniya's competitive edge in medical is most visible in large corporate and quasi-government accounts. The company re-won the Saudi Arabian Airlines employee scheme in 2023 after losing it four years earlier — a single contract exceeding 5% of that year's gross written premium — and has retained the STC group scheme won in 2022.⁹ In August 2025 it announced a three-year cooperative health insurance agreement with شركة المياه الوطنية the National Water Company, again disclosed as exceeding 5% of prior-year total revenue, effective from 25 August 2025.¹²

The concentration cuts both ways. Contracts of that size are lumpy, they tender competitively, and management has itself acknowledged that retention among the largest corporates is relatively low because they rotate between the major insurers.⁹ Overall retention across the book is stronger — the CEO put it at 85%, with certain products renewing at around 90% — but the accounts that move the revenue line are precisely the ones least locked in.¹⁰

Motor: the segment that punishes optimism

If medical is a grinding cost-control business, motor is a cyclical one, and 2025 demonstrated exactly how violent that cycle can be.

Across the Saudi market, the motor segment's net insurance and investment result swung from a profit of SAR 481 million in 2024 to a loss of SAR 905 million in 2025 — a SAR 1.4 billion reversal, driven by insurance service expenses rising far faster than premium.³ That single line item explains most of why sector-wide net income fell 40.8% to SAR 2.2 billion, the industry loss ratio deteriorated to 89.3%, and return on equity halved to 7.8%.³

The mechanism is textbook and worth explaining plainly, because it recurs in every insurance market on earth. Motor policies are annual and the product is close to a commodity, so price is the primary competitive lever. When a market is growing — as Saudi motor was, on the back of enforcement — insurers can chase volume by cutting rates, and the resulting revenue shows up immediately. The claims from those underpriced policies show up over the following twelve to twenty-four months. So an insurer that relaxes pricing discipline reports excellent growth for a year, then reports the consequences. Premium is collected in advance; loss is recognised in arrears. The error is self-concealing until it isn't.

Tawuniya lived both halves of this. Between 2017 and 2021 it deliberately ceded motor share, prioritising profitability, and watched its position fall from around 13% to roughly 7%.⁹ After 2021 it reversed course hard, roughly doubling motor share from around 10% to 22% by 2024 — a genuinely remarkable execution in a fiercely contested segment.⁹ The company built an ecosystem around the policy rather than competing purely on price: fleet solutions, breakdown recovery, maintenance, and vehicle services, alongside AI-assisted underwriting intended to price individual risks more finely.

The honest read is that the ecosystem strategy is credible in retail motor and unproven in corporate motor. Value-added services can justify a premium to an individual buyer choosing between comparable policies. A corporate fleet tender is decided on price. And it was precisely two corporate motor policies, written in 2025 on assumptions that subsequently changed, that damaged the 2026 result — a point we will take up in full at the end.

Property & casualty: the giga-project business that isn't really Tawuniya's risk

The third leg is the one most connected to the Vision 2030 headlines and least connected to Tawuniya's own balance sheet.

P&C covers industrial property, energy, engineering, marine, and aviation — the construction and operation of refineries, stadiums, rail, resorts, and the enormous PIF-backed developments reshaping the Kingdom's map. Tawuniya has historically been the largest domestic insurer in this segment, holding roughly 22% share in 2023, and it has been awarded the lead role in sector-wide pooled arrangements including comprehensive Hajj and Umrah pilgrim insurance and, more recently, the inherent-defects insurance pool on behalf of the industry.⁹

Being the named underwriter on a multi-billion-riyal project is prestigious. It is not, however, the same as bearing the risk. The overwhelming majority of large P&C exposure is ceded to international reinsurers, because no Saudi insurer's capital base can absorb a total loss on a petrochemical complex. Tawuniya carried the largest net reinsurance expense of any listed Saudi insurer in 2025 — materially larger than any peer.³ The company's economics in this segment are therefore closer to a fronting-and-commission business than a risk-taking one: it originates the exposure, retains a modest slice, and passes the rest along.

That is a defensible model. It is also one whose profitability is set in London, Zurich, and Bermuda rather than Riyadh. When global reinsurance pricing hardens, Saudi P&C rates follow and domestic margins compress. When large engineering or energy losses occur, the reinsurance recovery protects the balance sheet but the gross claims still disrupt the reported quarter — which is precisely what happened in the second quarter of 2026.

Three businesses, three risk profiles: a scale-and-cost-control grind, a pricing-discipline cycle, and an origination franchise dependent on foreign capacity. Understanding how those pieces get governed — and by whom — requires turning to what happened in 2023.

---

↑ Back to Top

V. The 2023 Leadership Pivot: The GOSI Loop and Othman Alkassabi's Era

The corporate governance changes that occurred in 2023 warrant close examination, as the regulatory and ownership relationships shape the competitive environment in which Saudi insurers operate.

One executive, three chairs

In early 2023, Tawuniya's chief executive was Abdulaziz Al-Boug, who had led the company during the 2021 launch of its five-year strategic plan, "Strategy 2025." This plan focused on four main objectives: expanding revenue to become the region's largest insurer, exceeding one billion riyals in net profit, enhancing customer experience, and advancing digitalization.⁹ The strategy set a 2025 gross written premium target of 17 billion riyals and a market-share target of 26 percent, both of which the company achieved in 2023, two years ahead of schedule.⁹

Al-Boug resigned on April 2, 2023. Othman Alkassabi, who had joined Tawuniya in 2021 to manage its largest division, the medical and life insurance sector, was appointed acting chief executive the following day.¹³

The transition occurred because Al-Boug was appointed Governor of the General Organization for Social Insurance (GOSI), Tawuniya's largest shareholder. Following the merger of the Public Pension Agency into GOSI on August 1, 2021, GOSI's combined stake in Tawuniya stood at 36.77 percent, up from its own pre-merger holding of 17.88 percent and the pension agency's 18.89 percent.¹⁴

The consolidation of sector governance continued in August 2023, when the Saudi Cabinet approved the establishment of the Insurance Authority (هيئة التأمين) as a unified regulator. This new body consolidated supervisory powers previously shared between the Saudi Central Bank (SAMA) and the Council of Health Insurance (مجلس الضمان الصحي). The Authority commenced operations on November 23, 2023, and assumed full regulation of health insurance from the council in March 2024.¹⁵⁹ Shortly after its creation, the Minister of Finance confirmed a Royal Order appointing Abdulaziz bin Hassan Al Boug as Chairman of the Insurance Authority—in addition to his role as GOSI Governor.¹⁶

Consequently, by late 2023, the former chief executive of the dominant insurer chaired the regulatory body supervising the industry, while also leading the public pension organization that held the largest block of Tawuniya's shares.

The stress test a skeptical investor should run

This governance structure can be interpreted in two ways. One interpretation suggests a risk of regulatory alignment with the incumbent's interests. A regulator chaired by the former head of the market leader might implement policies that favor scale, such as stricter capital and solvency requirements that pressure smaller carriers to consolidate. The Insurance Authority has used regulatory standards to encourage consolidation and has intervened directly in the market, including suspending one insurer's motor sales due to governance issues.⁹ While these actions do not indicate favoritism, they show that regulatory decisions have a significant impact in a concentrated market where the top five insurers control more than 78 percent of gross written premiums, and the top two account for nearly half.⁹

An alternative interpretation is that this structure imposes constraints on Tawuniya rather than protecting it. A regulator with direct experience in the company's operations can enforce oversight more effectively. Furthermore, as a state pension fund whose mandate aligns with Vision 2030 (رؤية ٢٠٣٠) goals, GOSI is not a passive shareholder. From this perspective, Tawuniya's capital allocation may be directed toward state-backed priorities, such as underwriting giga-project risks, managing industry pools, or supporting public health insurance reforms, which may not always represent the highest-yield opportunities for minority shareholders.

The available evidence does not favor one interpretation over the other. However, these dynamics suggest that the interests of minority shareholders and the state may not always align. Changes in regulatory policies concerning tariff pricing, capital adequacy, or mandatory reinsurance cessions must be evaluated in light of this ownership structure.

The operator who came from the other side of the table

Tawuniya's board approved Alkassabi's permanent appointment as chief executive on September 3, 2023, effective September 6.¹⁷ His professional background indicates where the company sees opportunities to improve its operating margins.

Alkassabi is not a career insurance underwriter. He trained in rehabilitation sciences and physical therapy at King Saud University, earned a master's degree in business administration from Hochschule Furtwangen University in Germany and a master's degree in international management and leadership from Al Yamamah University, and worked for more than seventeen years in healthcare.¹⁷ His career includes senior positions at the Council of Health Insurance, where he served as Executive Director of Supervision and Enablement, and business development roles at healthcare providers, including مستشفى الملك فيصل التخصصي King Faisal Specialist Hospital.¹⁷

This background provides experience from both the regulator's perspective in health insurance supervision and the provider's side within hospital administration. As a result, the chief executive has direct insight into claims leakage, utilization rates, billing practices, and the pricing differentials between healthcare delivery and insurance reimbursement.

Alkassabi's public statements have consistently emphasized this strategic direction. In a December 2023 interview, he noted that Tawuniya held approximately 27 percent market share and led in two of the three primary insurance segments. He outlined plans to establish subsidiaries, including a digital-first insurer targeting younger demographics, a primary healthcare provider, and new lines of coverage such as pet insurance, subject to regulatory approval.¹⁸ The stated goal is to transition Tawuniya into an integrated services group rather than a conventional risk-transfer agent, extending its reach into primary care clinics, automotive services, credit insurance, and digital distribution.¹⁹ To support this transition, the company's direct technology investments, particularly in artificial intelligence applications, exceeded 180 million riyals by mid-2024.²⁰

While the strategy has remained consistent from 2023 through 2026, and several planned subsidiaries are now operational, their financial performance remains to be fully demonstrated. This raises the question of how the company allocates its capital to support these initiatives.

↑ Back to Top

VI. The New Horizon: Tree, Riyadh Re, and Vertical Integration

Around 2022, the Saudi insurance sector entered a period of consolidation. While companies discussed thirteen mergers and completed six—including Arabian Shield with Alinma Tokio Marine, Walaa with SABB Takaful, Aljazira Takaful with Solidarity Saudi Takaful, Gulf Union with Al Ahlia, and Walaa with MetLife AIG ANB—smaller carriers under pressure from regulatory capital requirements and narrow underwriting margins sought partners.⁹ At the time, thirteen of the Kingdom's twenty-six listed insurers operated with paid-up capital below five hundred million riyals.⁹

Tawuniya participated in none of these acquisitions. In a market where distressed books of business were available at potentially discounted prices, the country's largest insurer chose not to consolidate horizontally. Instead, management directed capital downward into the value chain rather than expanding sideways.

This strategic pivot warrants evaluation.

The case against buying competitors

The rationale for avoiding acquisitions is straightforward. Acquiring another insurer means taking on its reserves—its estimates of claims that have occurred but have not yet been settled or reported. Because reserving requires management judgment, an acquirer risks inheriting under-reserved books. A struggling carrier under capital pressure faces a strong incentive to understate these future liabilities, making any acquisition a potential actuarial risk.

Furthermore, Tawuniya did not require acquisitions to find new customers. It was already expanding its market share organically across its core medical and motor segments. Horizontal mergers would have added premium that the company was already capturing through its own distribution, while introducing integration friction and legacy liabilities.

However, vertical expansion carries distinct risks, representing capital allocation to sectors where the insurer has no operational track record. This diversification into adjacent operations can dilute overall returns and complicate the group's financial structure. Increased corporate complexity makes segment economics less transparent, potentially obscuring underperformance in newer ventures within consolidated results.

An examination of these new ventures—a digital distribution brand, a primary healthcare provider, and a startup reinsurance carrier—illustrates these operational trade-offs.

Tree: digital distribution as counter-positioning

Tree is Tawuniya's wholly-owned digital insurance brand. Launched as the Kingdom's first fully digital insurer, it initially focused on retail motor before expanding into small-and-medium enterprise lines, travel, and pet insurance.¹⁸²¹ By early 2026, it had underwritten more than one hundred and forty-one thousand policies, boasting an average policy issuance time of under two minutes, as the group's digital technology sales rose to exceed twenty-five percent of its total sales—a leading figure among Saudi peers in both consumer and business channels.⁹

The strategic intent behind Tree is digital counter-positioning: establishing a direct-to-consumer channel that conventional brokers cannot match on speed or acquisition cost. Digitally native distribution offers a lower-cost model for acquiring retail motor and small commercial business, a demand already demonstrated by the growth of independent aggregator platforms in the Kingdom.

Yet this approach contains an inherent structural conflict: Tree competes for customers that Tawuniya could otherwise sign directly. Each policy Tree issues at a lower rate risks cannibalizing Tawuniya's higher-margin direct business. True counter-positioning typically works when an incumbent cannot respond to a challenger without damaging its legacy operations. Because Tawuniya owns both brands, the digital offering functions less as a competitive moat and more as a channel-mix optimization tool.

Meena Health: the Kaiser question

Meena Health represents a more capital-intensive initiative. Established in 2023 as a wholly owned subsidiary capitalized with five hundred million riyals, Meena operates primary healthcare clinics alongside virtual and home-based health services.²² Management's expansion plan is ambitious, projecting forty-eight healthcare facilities across sixteen regional clusters by 2028—covering Riyadh, Dammam, Makkah, Jeddah, and Madinah—with an interim target of forty-six to fifty-two centers by 2027.⁹²² The subsidiary's leadership has estimated the Saudi primary care market at approximately fourteen billion riyals, targeting a twenty to thirty percent share within a decade.²²

This initiative mirrors the integrated payer-provider model utilized by organizations like Kaiser Permanente in the United States. In this structure, vertical integration shifts the financial incentives of healthcare delivery. While a conventional insurer reimbursing third-party hospitals on a fee-for-service basis struggles to limit clinical over-utilization, a carrier that owns its clinics directly benefits from preventive care. By managing patient health proactively, the insurer aims to lower total claims costs, transforming primary care from a cost center into a margin-preservation tool.

This strategy faces two major challenges. First, the benefits of integrated care require significant scale and high patient alignment with owned clinics. A network of forty-eight primary care facilities is small relative to a customer base of millions of policyholders. Furthermore, medical inflation is concentrated in tertiary hospital admissions rather than primary care; while Meena can manage early-stage patient utilization, it has limited influence over the cost of specialized secondary or tertiary procedures. Second, financial analysts have noted that Meena is not projected to generate meaningful direct profits in the medium term. Instead, its success must be measured by improvements in Tawuniya’s overall medical loss ratios and customer retention rates rather than the subsidiary’s standalone earnings.⁹

While this strategic framing is coherent, it remains difficult to verify in the near term. For investors, the primary test of this capital deployment will be whether Tawuniya's core medical service margins show measurable improvement as the clinic network expands toward its 2028 target.

Riyadh Re: keeping the ceded premium at home

The third and most financially significant new venture is Riyadh Reinsurance Company. Tawuniya received a license from the Insurance Authority to establish this wholly owned subsidiary with five hundred and fifty million riyals in share capital, offering treaty and facultative reinsurance.²³ Incorporated on November 4, 2025, with that capital—equivalent to approximately one hundred and forty-six million dollars—Riyadh Re targets property, casualty, energy, engineering, marine, aviation, financial, and cyber lines. The subsidiary's first phase focuses on Saudi Arabia, the Gulf Cooperation Council, and the broader Middle East and North Africa, with plans to expand later into global reinsurance markets.²⁴

This venture addresses Tawuniya's substantial outbound premium flows. The company pays the highest net reinsurance expense among listed Saudi insurers, transferring a large volume of premium to international markets.³ By establishing a local reinsurance vehicle, the group seeks to retain a portion of this underwriting margin and investable float internally. Additionally, a domestic reinsurance subsidiary positions the group to benefit from local retention mandates while underwriting regional third-party risk.

However, this model introduces classic reinsurance risks. Underwriting reinsurance is highly capital-intensive and exposed to catastrophic losses. As a new entrant, Riyadh Re must compete with established global reinsurers, which often requires accepting higher-risk business or competing on price. Furthermore, a capital base of five hundred and fifty million riyals is small by international standards. Retaining risk that was previously ceded to international markets is only profitable if the underlying policies are priced accurately; if the risk was ceded because it was structurally unprofitable, retaining it converts a premium expense into direct underwriting losses. As of August 2026, Riyadh Re is approximately nine months old and has no public underwriting track record, meaning it represents an unproven option rather than a reliable driver of valuation.

Taken together, these three initiatives represent a strategy to control distribution, manage healthcare delivery costs, and retain underwriting capacity. While this expansion has been funded without taking on legacy liabilities, the integrated business model has yet to be tested through a complete underwriting cycle. The immediate analytical task is to evaluate the core competitive position upon which these investments are being built.

↑ Back to Top

VII. Porter's Five Forces & Hamilton Helmer's Seven Powers Analysis

Business frameworks are only valuable if applied objectively, which requires identifying areas where Tawuniya's position is less secure than its size suggests.

Hamilton Helmer's Seven Powers

Hamilton Helmer's framework seeks to identify the specific barriers that prevent competitors from replicating an incumbent's performance and driving its returns to zero. Applied to Tawuniya, four potential sources of power emerge, though none represents an absolute defense.

Scale economies — genuine, and the strongest of the four. Data from the first nine months of 2024 illustrates this advantage: while Tawuniya accounted for twenty-five percent of the Kingdom's gross written premiums, it captured thirty-four percent of the sector's total underwriting result and roughly a quarter of industry-wide net profit.⁹ Generating profitability that outpaces market share is a classic indicator of scale economies. This advantage is driven by the company's negotiating leverage with major hospital groups, alongside the ability to amortize fixed expenses—such as claims infrastructure, actuarial operations, and technology development—across a much larger premium base. For example, a smaller carrier with five hundred million riyals in capital cannot easily match the one hundred and eighty million riyals Tawuniya has invested in technology.

However, a key limitation remains: Bupa Arabia holds comparable scale in the medical segment, which represents nearly sixty percent of the Saudi insurance market. Scale economies shared with a primary rival do not generate excess returns against that competitor; instead, they protect both incumbents against smaller entrants. This dynamic is reflected in the high concentration of industry profits between the two leading carriers.

Cornered resource — real, but double-edged. The company's relationship with the Saudi state represents an asset that competitors cannot easily duplicate. GOSI's substantial shareholding, Tawuniya's forty-year history as a state-backed underwriter, its leadership of national insurance pools—including the Hajj and Umrah pilgrim coverage and the inherent-defects pool—and its capacity to underwrite massive giga-project risks provide a structural advantage that new entrants cannot purchase.⁹ This sovereign connection is central to the company's market position. At the same time, this relationship carries public obligations, and its value remains subject to shifts in government policy that lie outside management's direct control.

Switching costs — moderate, and weaker than commonly assumed. Changing providers for a large corporate medical contract involves significant operational friction, requiring the transfer of employee eligibility databases, hospital networks, authorization histories, and administrative procedures. This complexity supports a respectable overall customer retention rate of eighty-five percent.¹⁰ However, large corporate accounts are not entirely locked in; for instance, Tawuniya lost the Saudi Arabian Airlines scheme in 2021 and won it back in 2023, demonstrating that major contracts remain subject to competitive bidding.⁹ In the retail motor segment, switching costs are negligible, as digital comparison platforms allow consumers to change carriers within minutes. Consequently, switching costs provide a defense primarily in the middle-market corporate segment, while offering little protection at the high and low ends of the market.

Counter-positioning — weak. The digital brand, Tree, serves as an efficient distribution channel, but a subsidiary owned by an incumbent does not constitute counter-positioning under Helmer's definition. Because Tawuniya owns the digital platform, it faces no structural dilemma or collateral damage in operating it. Viewing this digital channel as a source of durable competitive advantage would overstate its strategic role.

Other potential sources of competitive advantage are absent. Insurance underwriting does not benefit from network effects, brand loyalty is secondary in a market driven by statutory mandates, and proprietary operational processes can be replicated over time by well-capitalized rivals. Tawuniya's competitive defense rests primarily on its scale and its access to state-linked contracts. While this forms a significant barrier, it is not absolute.

Porter's Five Forces

Rivalry: intense. In the medical segment, two dominant carriers compete directly, while the motor segment remains fragmented and sensitive to price competition. The sector-wide underwriting loss in motor during 2025 highlights how quickly aggressive pricing rivalry can erode industry profitability.³ While ongoing market consolidation is reducing the total number of insurers, the remaining competitors are becoming financially stronger and more capable.

Supplier power: high and structurally entrenched. This force exerts pressure on two fronts. Dominant private hospital groups establish the cost baseline for medical claims, while global reinsurance companies dictate the terms and capacity of the property and casualty market. In both segments, Tawuniya must negotiate with concentrated counterparties that operate internationally and do not rely solely on the Saudi market. This input cost pressure is a primary challenge for the business, and the group's vertical-integration initiatives represent a direct attempt to mitigate it.

Buyer power: high for corporate clients, and high in aggregate for retail customers. Large corporate employers utilize professional brokers to run competitive tenders, frequently rotating their insurance providers to secure better rates. Individual retail buyers remain highly price-sensitive for policies they are legally required to maintain, and online aggregator platforms have made price comparison straightforward. Consequently, statutory demand provides premium volume rather than pricing leverage.

Threat of new entrants: low. The barriers to entry are substantial, including strict licensing processes, high minimum capital and solvency requirements, and the significant cost of building a competitive healthcare provider network. Furthermore, the Insurance Authority's policy favors industry consolidation over the entry of new carriers.⁹

Threat of substitutes: low in the short term, but notable over the longer term. Consumers and businesses cannot easily substitute legally mandated coverages. The primary risk of substitution is systemic, such as large employers or state-backed entities choosing to self-insure, or the government returning specific segments of the population to public health coverage. Because the growth of Saudi medical insurance depends on regulatory policy, changes in political direction represent a key variable for the sector's long-term prospects.

Net assessment: Tawuniya represents an established franchise operating in a sector characterized by regulatory-driven growth and limited pricing power. Under these conditions, the primary source of long-term advantage is cost efficiency rather than pricing premiums. Profitability in this environment depends heavily on underwriting discipline and operational execution, a perspective that informs the business lessons discussed in the following section.

↑ Back to Top

VIII. Playbook: Business & Investing Lessons

Three core principles from Tawuniya's trajectory apply to the broader business and investment landscape.

When the state mandates your product, your job changes

Most companies focus their resources on generating customer demand. A regulatory mandate eliminates that challenge but introduces a more complex operational problem.

Tawuniya's expansion over the past five years was largely driven by state policy, specifically health insurance rules linked to residency permits and an automated traffic enforcement system that raised motor compliance by seventeen percentage points.⁹ No level of marketing execution could have replicated this effect.

In a mandated market, rapid top-line growth is weak evidence of operational excellence, as every licensed competitor benefits from the same systemic tailwind. The key differentiator is the ability to price risk accurately and control claims costs—capabilities that are invisible in premium revenue and only manifest in the underwriting margin years later. For investors, the lesson is to remain skeptical of premium growth as a primary metric and prioritize underwriting margins. The fastest-growing carrier may simply be the one underpricing its risk.

Build the adjacent step rather than buy the neighbouring competitor

Tawuniya's decision to bypass horizontal acquisitions during a period of industry consolidation, choosing instead to deploy capital into clinics, digital distribution, and reinsurance, represents a distinct strategic choice.

Horizontal acquisitions typically purchase duplicate market share alongside the target's legacy reserving errors. In contrast, vertical integration targets the largest component of an insurer's cost structure: claims, which typically represent eighty to ninety percent of the cost base. A riyal spent reducing claims costs carries far more leverage than a riyal spent acquiring incremental premium.

However, this strategy requires strict execution discipline. Vertical integration into unfamiliar sectors carries substantial risk, as demonstrated by historical failures of insurers attempting to manage clinical operations directly. The true test of this model is whether the vertical assets improve core underwriting margins on a defined timeline. With the build-out of Meena Health, Tawuniya has established such a schedule, and investors must evaluate management's performance against these milestones.

Premium-driven underwriting is a self-correcting error, and the correction is expensive

Insurance remains one of the few industries where a company can record revenue today for a cost it has not yet fully determined, meaning that aggressive expansion and disciplined growth look identical for approximately two years.

The industry-wide Saudi motor results from 2024 and 2025 illustrate this cycle. A segment that generated a profit of 481 million riyals in one year fell to a loss of 905 million riyals the next, despite no fundamental change in driving behavior.³ The shift was driven entirely by the rates at which risk had been underwritten twelve to twenty-four months earlier.

For investors, this yields a practical heuristic: when an insurer grows premiums substantially faster than the rest of the market, the default assumption should be that the growth was secured through aggressive pricing. Only when the loss ratios for that specific underwriting cohort develop can it be attributed to underwriting skill. For management, the primary defense against this cycle is a willingness to walk away from unprofitable volume—and, when a mispricing is identified, to refuse renewals rather than protect market share.

This is the exact test Tawuniya faced in 2026.

↑ Back to Top

IX. Balanced Bull vs. Bear Case & KPIs to Track

The bull case

The Health Sector Transformation Program is a structural demand event. Saudi Arabia's healthcare reform agenda envisages roughly $65 billion of infrastructure investment and a rise in private-sector participation from 20% to 35% by 2030, including the privatisation of some 290 hospitals and 2,300 primary healthcare centres.²⁵ The financing implication is that populations currently covered directly by government budgets migrate toward insured models. Tawuniya, as the largest carrier with the deepest state relationships, is positioned to capture a disproportionate share.

The enforcement gap remains the cheapest growth available anywhere in the sector. As discussed, closing the medical enforcement gap alone would add roughly SAR 10.9 billion of premium at current average pricing, and lifting motor compliance from 68% toward the 90% policy target would add approximately SAR 3.8 billion of motor premium.⁹ Neither requires a single new customer to be persuaded of anything.

Product mix has room to shift upward in value. Only about 30% of Saudi motor policies are comprehensive, against roughly 90% in the UK and 80% in the US.⁹ Comprehensive premiums run near double basic third-party liability. Conversion toward comprehensive is a revenue-per-policy lever independent of volume — and it is precisely the lever an ecosystem of maintenance, recovery, and vehicle services is designed to pull.

Claims infrastructure is being digitised. The national platform for health and insurance data exchange — المنصة الوطنية الموحدة لخدمات تبادل البيانات الصحية NPHIES — routes clinical and financial claims data between providers and insurers on standardised international classifications, with the explicit objective of transparency and administrative efficiency across health transactions.²⁶ For a payer processing millions of claims, standardised electronic adjudication reduces administrative cost and, more importantly, makes fraud and duplicate billing detectable at scale.

Scale is translating into disproportionate profit. Tawuniya has been converting share into a larger share of industry earnings than of industry premium, and its combined ratio improved by over 130 basis points to 97% in 2024 with underwriting margin expanding for a second consecutive year.⁹ That is the pattern one wants to see: growth accompanied by margin, not purchased with it.

The bear case

Medical cost inflation is the structural threat, and the payer is on the wrong side of it. Private medical inflation in the Kingdom has run persistently above general inflation, and repricing power has diminished after two cumulative years of substantial increases, with rising risk of customers down-trading to cheaper policies.⁹ An insurer squeezed between provider tariffs it cannot dictate and corporate buyers who tender annually has a margin, not a franchise.

The 2025 sector experience shows how thin the underwriting cushion is. An industry loss ratio of 89.3% means roughly ninety fils of every riyal of revenue goes straight back out as claims before a single riyal of expense is counted.³ There is very little room for error, and a single mispriced cohort in a single segment can erase a year of progress.

Investment income is a declining crutch. Falling benchmark rates reduce the yield on float, and because medical and motor are one-year products the investment book is necessarily short-duration and reprices quickly. Sell-side modelling anticipated the share of investment income in profitability declining from 36% in 2024 to under 18% by 2027.⁹ Underwriting has to carry more of the load, in a market where underwriting is hard.

Regulatory risk cuts both ways. The Insurance Authority has demonstrated willingness to intervene directly in carriers' operations, and further capital, solvency, or pricing requirements would compress return on equity.⁹ More subtly, an insurer that has benefited from tightening enforcement is an insurer whose growth is contingent on a policy stance that could soften.

The activist's questions. A skeptical investor would press on several fronts. Portfolio complexity: the group now contains a digital insurer, a healthcare provider, a reinsurer, and vehicle services, and other operating expenses tied to subsidiary expansion have been explicitly cited as a drag on reported earnings — SAR 418.3 million in H1 2026, up 21.6%.⁵²⁷ Segment transparency: without visibility into each venture's standalone economics, it is difficult to assess whether the ecosystem is subsidising the core or the reverse. Governance: the ownership-and-regulator structure described earlier. Concentration: contracts individually exceeding 5% of revenue create meaningful re-tender risk. And accountability: the 2026 motor problem originated in decisions made in 2025, which raises a fair question about underwriting controls on large corporate risks.

Management credibility — the balanced read. The record is genuinely mixed in a way that favours management modestly. On the positive side, Strategy 2025's targets were exceeded two years ahead of schedule, the narrative has been consistent across years of public appearances, and when the 2026 problem emerged the explanation was specific rather than macro hand-waving — three named causes, an identified cohort of policies, and a stated remedy.²⁷ On the cautious side, the aggressive motor share expansion of 2021–2024 is exactly the behaviour that produced the industry's 2025 losses, and the company was not immune. An investor should credit the disclosure quality while remaining sceptical that the underwriting error is fully behind the book.

The three KPIs that actually matter

Resist the temptation to track everything. For this company, three numbers carry the signal.

1. Net insurance service margin and the combined ratio. This is the single most important measure of whether the business is underwriting profitably rather than growing profitably. The combined ratio expresses claims plus expenses as a percentage of premium: below 100% means the underwriting itself makes money before any investment return. Tawuniya's combined ratio was 97% in 2024, against an industry loss ratio that deteriorated sharply in 2025.⁹³ Sustained improvement here validates the entire scale-and-integration thesis. Deterioration invalidates it, regardless of what revenue does.

2. Gross written premium growth in medical, measured against Bupa Arabia specifically. Not total GWP — medical GWP versus the one competitor with comparable scale. This is where the market share contest is genuinely decided, and where the difference between winning on service and winning on price will eventually show up. Watch it alongside the medical loss ratio; growth accompanied by a stable loss ratio is skill, growth accompanied by a rising one is discounting.

3. Net investment income and portfolio yield. With a float above SAR 13 billion, investment performance is a material swing factor in reported net income, and it is the line most exposed to the interest-rate cycle.⁵ Its declining contribution is the reason underwriting discipline is becoming non-negotiable.

These are figures to monitor as they are reported, not to project. The disclosure exists; the discipline is in reading it consistently.

---

↑ Back to Top

X. Epilogue: The H1 2026 Profit Decline and Course Correction

Tawuniya's financial results for the first half of 2026 showed a clear divergence between top-line expansion and falling profitability. For the six months ending June 30, 2026, insurance revenue rose 15.9 percent to 11.996 billion Saudi riyals, and gross written premiums grew by approximately 21 percent to 14.5 billion riyals. Yet net profit declined by 16.4 percent to 609.85 million riyals, down from 729.11 million riyals in the first half of 2025.²⁷ The pressure was most acute in the second quarter, when net profit fell by 31.2 percent year-on-year to 321.77 million riyals, representing the steepest quarterly drop in more than two years and reversing the 10.1 percent growth recorded in the first quarter.²⁷²⁸

Three causes, none of them the same problem

Chief Executive Othman Alkassabi attributed the deterioration in underwriting performance to three distinct factors, each carrying different operational implications.¹⁹

First, large general insurance claims occurred within the engineering and energy segments. Although the company noted that the majority of these losses were recovered from reinsurers,²⁷ the event highlights a characteristic of the property and casualty fronting model: while reinsurance protects the balance sheet from net losses, large gross claims still introduce volatility into quarterly reported earnings. For a portfolio heavily exposed to giga-project construction, such fluctuations represent a structural feature rather than an operational failure.

Second, seasonality in the health insurance segment affected the timing of earnings. Because large corporate medical contracts renew disproportionately during the first quarter, premium revenue is recognized early in the year, whereas the associated claims develop more evenly over subsequent quarters. This mismatch is a characteristic of seasonal corporate accounts rather than a decline in underlying performance.

Third, the performance of the motor portfolio diverged between retail and corporate segments. The segment was pressured by higher loss ratios on two corporate motor policies underwritten in 2025, whose underlying assumptions did not hold under changing market conditions; this deterioration was only partially offset by improvements in the retail motor book.²⁷ This contrast suggests that while value-added retail services and digital pricing models supported margins among individual buyers, large corporate fleet tenders remained highly sensitive to price competition, leading to underwriting losses when claims exceeded initial estimates.

Mitigating the underwriting pressure, net investment income rose 12.9 percent to 416.1 million riyals, supported by an 11.1 percent expansion of the investment portfolio to 13.5 billion riyals. Alkassabi attributed this performance to strategic asset allocation and an emphasis on low-risk, long-duration assets during a period of market volatility.²⁷¹⁹ Conversely, other operating expenses grew 21.6 percent to 418.3 million riyals, reflecting the ongoing capital requirements of building out the company's new healthcare and digital subsidiaries.²⁷

The response, and how to read it

Management announced that it will not renew the two underperforming corporate motor contracts, stating that the underwriting losses were tied to premiums recognized from the previous year's pricing decisions.¹⁹

This response presents two analytical interpretations. On one hand, declining to renew high-volume accounts to protect margins is a standard corrective measure in disciplined underwriting. Walking away from substantial premium volume, rather than attempting to adjust rates incrementally while retaining the business, suggests that management is prioritizing profitability over market share—a notable choice given the sector-wide motor underwriting losses of 1.4 billion riyals in 2025.³

On the other hand, attributing a segment-wide margin decline to just two contracts warrants caution. It remains unclear whether the underwriting issues were isolated to these specific policies or if they indicate broader systemic weaknesses in Tawuniya's commercial motor pricing during its recent period of rapid market share growth. Because a single half-year disclosure is insufficient to resolve this, the sustainability of the segment's recovery will depend on whether commercial motor loss ratios normalize in subsequent quarters.

This underwriting pressure occurred alongside changes in the company's capital structure. The board recommended a cash dividend of two riyals per share for 2025, totaling 300 million riyals, alongside a 50 percent capital increase through the issuance of one bonus share for every two shares held. This transaction capitalized 750 million riyals from retained earnings, increasing the company's capital from 1.5 billion riyals to 2.25 billion riyals.²⁹ While retaining earnings to expand the capital base supports Tawuniya's long-term vertical integration into reinsurance and clinics, it also requires shareholders to support capital-intensive projects whose financial returns remain unproven, even as core underwriting profits have declined.

What the whole arc actually demonstrates

Tawuniya's trajectory since its establishment in 1986 illustrates the transition from a state-sponsored compliance prototype to the largest commercial insurer in the Middle East. The company has diversified into digital distribution, primary care clinics, and reinsurance, achieving higher premium volume and, in 2025, greater net profitability than its main specialized competitor.

This development indicates that while government mandates and state relationships provide significant opportunities, they do not guarantee commercial success. Several smaller Saudi insurers, capitalized at under 500 million riyals, have struggled to grow despite operating under the same regulatory mandates.⁹ Tawuniya's growth has depended on leveraging its scale to secure corporate accounts and manage provider costs, alongside direct investments in its digital and physical infrastructure.

However, the results from the first half of 2026 highlight the limitations of this scale. The cooperative legal structure, sovereign backing, and vertical integration projects do not insulate the carrier from underwriting cycles or pricing errors. In insurance, where premium revenue is recorded long before the ultimate cost of claims is determined, operational performance depends on underwriting discipline and risk-selection controls. The effectiveness of management's corrective measures and the viability of its vertical integration strategy will ultimately be reflected in the stabilization of its reported loss ratios in future quarters.

References

1. Tawuniya Annual Report 2022 — Notes to the Consolidated Financial Statements ↩↩

2. Tawuniya: 2025 results — Atlas Magazine ↩↩↩

3. KSA Insurance Industry Update: Year-End 2025 — Milliman, 2026-06-04 ↩↩↩↩↩↩↩↩↩↩↩↩↩

4. Surplus Distribution Policy — SAMA Rulebook ↩↩

5. KSA Industry Update Year-End 2025 (summary) — Milliman ↩↩↩

6. Cooperative Insurance Companies Control Law in Saudi Arabia — Saudipedia ↩

7. Company for Cooperative Insurance (Tawuniya) — Saudipedia ↩

8. Healthcare Transformation in Saudi Arabia: An Overview Since the Launch of Vision 2030 — PMC ↩

9. Saudi Insurance Sector — Initiation of Coverage — ANB Capital, 2025-04-16 ↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩↩

10. Health insurance accounts for 81% of GWP: Tawuniya CEO — Argaam ↩↩↩

11. Bupa Arabia for Cooperative Insurance Company Reports Earnings Results for the Full Year Ended December 31, 2025 — MarketScreener ↩↩

12. Tawuniya wins deal to provide health insurance services to NWC — Argaam, 2025-08-18 ↩

13. Tawuniya names Othman Alkassabi Acting CEO after Abdulaziz Al-Bouq resigns — Argaam, 2023-04 ↩

14. A look at GOSI stakes in Tadawul-listed firms post-merger with PPA — Argaam ↩

15. Establishment of the Insurance Authority in the Kingdom of Saudi Arabia — Clyde & Co, 2023-09 ↩

16. Abdulaziz Al Boug named Chairman of Insurance Authority — Argaam ↩

17. Tawuniya names Othman Alkassabi as CEO — Argaam, 2023-09 ↩↩↩

18. Tawuniya holds 27% market share, eyes new products: CEO — Argaam, 2023-12-21 ↩↩

19. Tawuniya CEO: Insurance ops impacted by 3 key factors — Argaam, 2026-08 ↩↩↩↩

20. Tawuniya's tech investments exceed SAR 180M: CEO — Argaam ↩

21. Tawuniya Investor Relations Portal — Tawuniya ↩

22. Tawuniya's Meena Health plans to open up to 52 centers by 2027 — Argaam, 2024-10-22 ↩↩↩

23. Tawuniya gets IA nod to set up Riyadh Re with SAR 550M capital — Argaam ↩

24. Riyadh Re launches with $146m capital to build Saudi reinsurance hub — Global Reinsurance ↩

25. Saudi Arabia Healthcare Industry Reforms — International Trade Administration ↩

26. The development of the Saudi Billing System supporting national health transformation — BMC Health Services Research ↩

27. Financial Results: Tawuniya H1 2026 — Argaam ↩↩↩↩↩↩↩↩

28. Tawuniya: Q1 2026 results — Atlas Magazine ↩

29. Tawuniya proposes SAR 2/shr dividend, bonus issue — Argaam ↩